EUVIMEDEUVIMED entdecken
Open Access

Hypoxia-inducible factor–1α–dependent induction of miR122 enhances hepatic ischemia tolerance

Cynthia Ju, Meng Wang, Eunyoung Tak, Boyun Kim, Christoph Emontzpohl, Yang Yang, Xiaoyi Yuan, Huban Kutay, Yafen Liang, David R Hall, Wasim A Dar, J Steve Bynon und 3 weitere

Journal of Clinical Investigation · 01.04.2021 · 131 (7)

DOI: 10.1172/jci140300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2021. Verfasst von Cynthia Ju und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Texas, USA. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsFemaleHepatocytesHumansHypoxia-Inducible Factor 1, alpha SubunitIschemiaLiverLiver DiseasesMaleMiceMice, TransgenicMicroRNAsReperfusion Injury

Stichwörter der Autor:innen

GastroenterologyGene therapyHypoxiaOrgan transplantationTransplantation

Substanzen

HIF1A protein, humanHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMIRN122 microRNA, humanMicroRNAsMirn122 microRNA, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Texas, USA.
  • Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Department of Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, and.
  • Center for Cancer Biology, Department of Oncology, Katholieke University Leuven, Leuven, Belgium.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • Crohn’s and Colitis Foundation of America

Zitieren

APA

Ju, C., Wang, M., Tak, E., Kim, B., Emontzpohl, C., Yang, Y., Yuan, X., Kutay, H., Liang, Y., Hall, D. R., Dar, W. A., Bynon, J. S., Carmeliet, P., Ghoshal, K., & Eltzschig, H. K. (2021). Hypoxia-inducible factor–1α–dependent induction of miR122 enhances hepatic ischemia tolerance. Journal of Clinical Investigation, 131(7). https://doi.org/10.1172/jci140300

Vancouver

Ju C, Wang M, Tak E, Kim B, Emontzpohl C, Yang Y, et al. Hypoxia-inducible factor–1α–dependent induction of miR122 enhances hepatic ischemia tolerance. Journal of Clinical Investigation. 2021;131(7). doi:10.1172/jci140300

BibTeX
@article{Ju2021,
  author = {Ju, Cynthia and Wang, Meng and Tak, Eunyoung and Kim, Boyun and Emontzpohl, Christoph and Yang, Yang and Yuan, Xiaoyi and Kutay, Huban and Liang, Yafen and Hall, David R and Dar, Wasim A and Bynon, J Steve and Carmeliet, Peter and Ghoshal, Kalpana and Eltzschig, Holger K},
  title = {Hypoxia-inducible factor–1α–dependent induction of miR122 enhances hepatic ischemia tolerance},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  volume = {131},
  number = {7},
  doi = {10.1172/jci140300}
}
Kostenlos starten →